-
AMX0035
More (and very positive!) news is coming out about AMX0035. From press releases, to webinars, to reports from clinical trial participants.
Here is a listing of current news this week:
Webinars
- “Long-Term Survival of Participants in the CENTAUR Trial” Oct. 21, 2020. Sabrina Paganoni, MD, PhD and Merit Cudkowicz, MD, MSc from the Sean M. Healey & AMG Center for ALS at Mass General Hospital. More at: https://www.neals.org/for-people-with-als-caregivers/educational-webinars/
- “Open Label Extension Study Results of AMX0035: Implications for People with ALS” Oct. 21, 2020. In this session, Dr. Neil Thakur and Dr. Kuldip Dave from The ALS Association will talk about the implications of additional results from the Open Label Study of the CENTAUR trial for the ALS community. They will discuss The ALS Association’s plans for helping the ALS community influence when AMX0035 might be approved for clinical use. Dr. Jinsy Andrews, NEALS co-Chair and Association Trustee, will moderate audience questions. More at: https://register.gotowebinar.com/register/3880047202378628109?utm_source=102120+Thakur+Dave+Webinar+&utm_campaign=102120+ALSA+Webinar+&utm_medium=email
- ALS News Today article: https://alsnewstoday.com/news-posts/2020/10/19/amylyxs-amx0035-significantly-extends-als-patients-lives-long-term-trial-data-show-also-slows-functional-decline/
If you know of other news or updates about AMX0035, please add it in the comment section below.
Log in to reply.